Skip to navigationSkip to contentSkip to footerHelp using this website - Accessibility statement
Advertisement
Companies

Healthcare & Fitness

This Month

Australians are increasingly turning to telehealth services for their health needs.

Consumers leaning in to telehealth convenience

Amid doctor shortages and overwhelmed GP practices, patients are turning to telehealth for a wide range of services including medical consultations and prescriptions.

Sponsored 

by Hola Health

‘Don’t just lie there,’ Dr Moire Junge, The Sleep Foundation CEO.

Why this sleep expert wants everyone to stop worrying about sleep

Anxiety about not getting enough sleep has become a problem in itself. Here’s what you can do about it - and a bit of late night TV is OK.

  • Emma Connors
Cura runs a string of day surgeries around the country.

Intermediate Capital Group set to acquire Cura Day Hospitals

ICG knows Cura well, having funded a management buyout from Archer Capital in 2014.

  • Sarah Thompson, Kanika Sood and Emma Rapaport
US Federal Reserve chairman Jerome Powell: Let the pivot party begin.

What really matters now for investors, and nine more opinion reads

Here are 10 opinion pieces from the week.

Mark Finocchiaro, managing partner Chemist Warehouse, owns eight pharmacies in the group.

Inside the Chemist Warehouse franchisee world

There are over 200 managing partners who are shareholders in the discount chain. They are all ambitious pharmacy owners, many with multiple sites.

  • Carrie LaFrenz
Advertisement
Healius shares rose sharply during the COVID-19 pandemic but have lost $2b in market value.

ACL pulls Healius bid as ACCC blocks pathology shake-up

Australian Clinical Labs, the No.3 player in the pathology market, has not given up in its chase for ailing No.2 player Healius.

  • Simon Evans
Mike Baird: Looking to the next challenge.

Mike Baird flags HammondCare exit

If Peter Dutton was hoping to recruit Mike Baird to run for the Liberals in a teal-held NSW seat, he had better get started now.

  • Myriam Robin
Sigma Healthcare deal could be the M&A transaction of the year.

Chemist Warehouse deal will make Sigma stock a global attraction

The deal name, Project Orbit, says it all. Hats off to this sleepy wholesaler for rocketing into the large-cap universe and catching the eye of US giants.

  • Anthony Macdonald
Sigma chief executive Vikesh Ramsunder will remain at Sigma following merger with Chemist Warehouse.

Chemist Warehouse top brass to remain in Sigma merger

The drug wholesaler and distributor took the weekend to hammer out the last details of the reverse takeover by the pharmacy giant.

  • Carrie LaFrenz
Chemist Warehouse’s deal to list via Sigma Healthcare is due to be signed in coming days.

How Chemist Warehouse’s backdoor deal passes ASX pub test

How do you backdoor list a big company that is majority owned by two founders and their families and still have enough free float? Now, we have the answer.

  • Anthony Macdonald
Chemist Warehouse’s deal to list via Sigma Healthcare is due to be signed in coming days.

Eight-year quest to float Chemist Warehouse ends abruptly

Missing Chemist Warehouse’s IPO would be a career limiting move. But when the whole street misses it, play on.

  • Anthony Macdonald
Medibank chief executive David Koczkar.

Medibank Private secures binding deal to lift Myhealth stake

It is understood the listed insurer will go from owning about 33.3 per cent of the GP clinics chain to 66.66 per cent at a $260 million valuation.

  • Sarah Thompson, Kanika Sood and Emma Rapaport
Nicolab’s StrokeViewer aims to streamline stroke treatment.

Soul Patts-backed IPO hopeful Nicolab back in front of investors

The Amsterdam-based medtech is back on the fund-raising trail just seven months after its last cash call.

  • Sarah Thompson, Kanika Sood and Emma Rapaport
Healius CEO Maxine Jaquet at the annual meeting on November 28.

Why it’s so hard to make money from blood tests

There’s restructuring ahead at the No. 2 pathology provider Healius, which despite its activist ructions, has yielded a 30 per cent return since its 2023 low.

  • Simon Evans
Biotech company Mesoblast is focused on creating a treatment for the worst-effected COVID-19 patients.

Mesoblast taps Bell Potter for $98m equity raising

The biotech company launched its latest raising on Friday morning to fund clinical trials.

  • Sarah Thompson, Kanika Sood and Emma Rapaport
Advertisement

November

NVP’s network spans 150 psychologists.

Quadrant’s Partnered Health buys psychology platform

The private equity firm has signed a deal to bring New View Psychology, a 17-year-old business that connects organisations with psychologists, into its stables.

  • Sarah Thompson, Kanika Sood and Emma Rapaport
Greencross has more than 260 stores and 160 GP vet clinics in Australia.

TPG Capital extracts bumper $575m dividend from Greencross

The capital return for the Petbarn company comes as the softer economic environment makes it harder for private equity to sell companies.

  • Primrose Riordan
Federal Court Justice Wendy Abraham.

Court blocks telehealth consultations for euthanasia

Federal Court judge says a Commonwealth law banning the use of the phone or internet to “counsel” suicide prevails over state laws.

  • Michael Pelly
Former St Vincent’s chief executive and freshly minted 
Integral Diagnostics chair Toby Hall.

Integral Diagnostics chair pops up for Partners Group at Cura auction

The Zug-headquartered private equity firm is serious about its tilt as it jostles with Intermediate Capital Group and a Medibank/Macquarie consortium.

  • Sarah Thompson, Kanika Sood and Emma Rapaport
Chris Nasr and Grace Tan, founders of Nectar Brands.

Meet the Fast Starters building healthcare empires

Health companies make up about 10 per cent of this year’s list, reflecting demand for better, cheaper and more convenient access to products and services.

  • Ronald Mizen